20
Arevipharma Gmbh Radebeul De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Hydrochlorothiazide, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-012 - Rev 02
This Chemical Type CEP, issued on July 12, 2017, remains in force until July 19, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 394 associated with this CEP further emphasizes